Institutional Ownership Cyclo Therapeutics, Inc. (CYTH)
This table provides information about the institutional ownership of Cyclo Therapeutics, Inc. (CYTH). We have compiled data on the 21 institutions that hold shares in the stock, with a total of 2.24 Million shares, which have been reported (via 13F filing form) to have a value of $1.68 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Epiq Capital Group, LLC
San Francisco, CA |
Feb 07, 2025 Q4 2024 |
689,447
shares
|
$510,190
0.11% of portfolio
|
Q4 2024
Reduced 6.76%
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
598,694
shares
|
$443,033
0.0% of portfolio
|
Q3 2024
Added 34.06%
|
|
Founders Fund V Management, LLC
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
480,708
shares
|
$355,723
16.84% of portfolio
|
Q4 2023
New holding
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
152,332
shares
|
$112,725
0.0% of portfolio
|
Q3 2024
Reduced 13.16%
|
|
Founders Fund Vi Management, LLC
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
110,023
shares
|
$81,417
100.0% of portfolio
|
Q4 2023
New holding
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
59,510
shares
|
$44,037
0.0% of portfolio
|
Q2 2024
Added 60.29%
|
|
Two Sigma Securities, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
42,541
shares
|
$31,480
0.0% of portfolio
|
Q4 2024
New holding
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
39,530
shares
|
$29,252
0.0% of portfolio
|
Q1 2024
Added 0.01%
|
|
Wealth Enhancement Advisory Services, LLC
|
Jan 10, 2025 Q4 2024 |
23,400
shares
|
$17,316
0.0% of portfolio
|
Q3 2024
Added 14.71%
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
21,736
shares
|
$16,084
0.0% of portfolio
|
Q4 2024
Added 0.06%
|
|
Ubs Group Ag
|
Feb 14, 2025 Q4 2024 |
11,987
shares
|
$8,870
0.0% of portfolio
|
Q4 2024
Reduced 3.78%
|
|
Tower Research Capital LLC (Trc)
New York, NY |
Feb 13, 2025 Q4 2024 |
6,684
shares
|
$4,946
0.0% of portfolio
|
Q4 2024
Added 23.89%
|
|
Wells Fargo & Company
San Francisco, CA |
Feb 12, 2025 Q4 2024 |
4,391
shares
|
$3,249
0.0% of portfolio
|
Q2 2024
Reduced 3.81%
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
1,031
shares
|
$762
0.0% of portfolio
|
Q2 2024
Reduced 0.58%
|
|
Royal Bank Of Canada
Toronto, A6 |
Feb 14, 2025 Q4 2024 |
746
shares
|
$552
0.0% of portfolio
|
Q4 2024
Reduced 9.14%
|
|
Jpmorgan Chase & CO
New York, NY |
Feb 12, 2025 Q4 2024 |
193
shares
|
$142
0.0% of portfolio
|
Q4 2024
Reduced 0.52%
|
|
Bank Of America Corp
Charlotte, NC |
Feb 14, 2025 Q4 2024 |
170
shares
|
$125
0.0% of portfolio
|
Q4 2024
Reduced 82.9%
|
|
Steward Partners Investment Advisory, LLC
|
Feb 06, 2025 Q4 2024 |
90
shares
|
$66
0.0% of portfolio
|
Q4 2023
New holding
|
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
Feb 07, 2025 Q4 2024 |
67
shares
|
$49
0.0% of portfolio
|
Q1 2024
Reduced 88.83%
|
|
Sbi Securities Co., Ltd.
Tokyo, M0 |
Feb 05, 2025 Q4 2024 |
11
shares
|
$8
0.0% of portfolio
|
Q4 2024
New holding
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Feb 13, 2025 Q4 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q4 2024
New holding
|